Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-11 Sale |
2024-12-13 6:41 pm |
CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner |
5,957,250 | $0.06722 | $400,456 | 13,005,169 (Indirect) |
View |
| 2024-12-06 Sale |
2024-12-10 8:44 pm |
CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner |
3,658,364 | $0.10479 | $383,370 | 18,962,419 (Indirect) |
View |
| 2024-09-25 Sale |
2024-11-20 4:04 pm |
CERO THERAPEUTICS HOLDINGS INC. | CERO | SLOAN STUART M 10% Owner |
532,486 | $0.1043 | $55,538 | 21,067,956 (Indirect) |
View |
| 2024-10-10 Sale |
2024-11-14 8:14 pm |
CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner |
3,250,000 | $0.1 | $325,000 | 22,620,783 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-30 Option Award |
2025-06-02 5:09 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director |
9,326 | $0 | 9,326 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 5:08 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director |
9,326 | $0 | 9,326 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 5:06 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director |
9,326 | $0 | 9,326 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 5:05 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director |
11,693 | $0 | 11,693 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 5:04 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
61,843 | $0 | 61,842 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 5:02 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
122,549 | $0 | 122,549 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 5:01 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Pierce Kristen Chief Development Officer |
154,841 | $0 | 154,841 (Direct) |
View |
| 2025-05-30 Option Award |
2025-06-02 4:57 pm |
N/A 2035-05-29 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | KUCHARCHUK ANDREW ALBERT Chief Financial Officer |
152,500 | $0 | 152,500 (Direct) |
View |
Ownership(A) |
2025-05-08 06:11 am |
N/A 2034-06-13 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Pierce Kristen Chief Development Officer |
0 | $0 | 659 (Direct) |
View |
| 2025-03-31 Exercise |
2025-04-04 7:12 pm |
2025-02-07 N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
294,460 | $0.0001 | 707,524 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:18 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director |
17,923 | $0 | 17,923 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:16 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director |
17,923 | $0 | 17,923 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:16 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director |
17,923 | $0 | 17,923 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:15 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director |
14,936 | $0 | 14,936 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:14 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
14,936 | $0 | 14,936 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:10 pm |
N/A 2035-03-03 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
119,486 | $0 | 119,486 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 6:06 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director |
127,500 | $0 | 255,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 6:03 pm |
N/A 2034-10-10 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director |
127,500 | $0 | 255,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 6:02 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director |
127,500 | $0 | 255,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 5:59 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
1,275,000 | $0 | 2,550,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 5:57 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director |
127,500 | $0 | 255,000 (Direct) |
View |
| 2025-02-24 Option Award |
2025-02-26 5:54 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
254,000 | $0 | 508,000 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-07 5:23 pm |
2025-02-07 N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
510,200 | $0.0001 | 1,020,400 (Direct) |
View |
| 2025-02-07 Option Award |
2025-02-07 5:23 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
510,200 | $1.9599 | 1,020,400 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:13 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO |
1,275,000 | $0 | 1,275,000 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:12 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director |
127,500 | $0 | 127,500 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:12 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director |
127,500 | $0 | 127,500 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:11 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director |
127,500 | $0 | 127,500 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:11 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
254,000 | $0 | 254,000 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-04 9:10 pm |
N/A 2034-10-10 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director |
127,500 | $0 | 127,500 (Direct) |
View |
Ownership |
2024-11-20 4:03 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | SLOAN STUART M 10% Owner |
0 | $0 | 21,600,442 (Indirect) |
View |
Ownership |
2024-11-14 8:12 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner |
0 | $0 | 25,870,783 (Indirect) |
View |
Ownership |
2024-10-11 4:15 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director |
0 | $0 | 1,435,252 (Indirect) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:53 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director |
965,997 | $0 | 971,825 (Indirect) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:53 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director |
50 | $1000 | 971,825 (Direct) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:53 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO |
5,312,983 | $0 | 5,795,408 (Direct) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:53 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO |
275 | $1000 | 5,795,408 (Direct) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:52 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
19,358,578 | $0 | 19,732,313 (Indirect) |
View |
| 2024-09-25 Exercise |
2024-10-02 9:52 pm |
N/A N/A |
CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director |
1,002 | $1000 | 19,732,313 (Indirect) |
View |
| 2024-10-01 Option Award |
2024-10-02 7:03 pm |
N/A 2034-09-30 |
CERO THERAPEUTICS HOLDINGS INC. | CERO | KUCHARCHUK ANDREW ALBERT Chief Financial Officer |
500,000 | $0 | 500,000 (Direct) |
View |